Sangamo BioSciences Announces Notice Of Allowance For New Patent Application Covering Genome Modification Technology
August 14, 2013 at 07:01 AM EDT
Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the U.S. patent application (US 20110301073) entitled "Novel DNA-binding Proteins and Uses Thereof." The claims cover core architectural aspects of engineered Transcription Activator-Like Effectors, or
